[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma

NCT07655869 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Recurrent High-Grade Gliomas
Recurrent Glioblastoma IDH Wildtype

Interventions

DRUG: [177Lu]Lu-DOTA-EB-RGD2

Sponsor

Beijing Tiantan Hospital